MDR Article 16: When a Distributor or Importer Becomes the Manufacturer

Most distributors and importers know Article 16 only as "the repackaging article." That undersells what it actually does. Article 16 of Regulation (EU) 2017/745 is the provision that decides when a distributor, importer, or other person stops being a supply-chain intermediary and starts carrying the full weight of a manufacturer's obligations under the MDR — technical documentation, conformity assessment, vigilance, the whole file. Getting the Article 16 assessment wrong is not a labeling error; it is discovering, mid-audit or mid-EU MDR & IVDR strategy review, that your organization has been the legal manufacturer of record without building anything a manufacturer is required to have.

The three triggers under Article 16(1)

Article 16(1) lists three ways a distributor, importer, or other natural or legal person assumes the obligations incumbent on manufacturers under the MDR:

• Own-brand labeling. Making a device available under your own name, registered trade name, or registered trademark — unless you have an agreement with the manufacturer under which the manufacturer is identified as such on the label and remains responsible for meeting the manufacturer requirements.
• Changing the intended purpose. Altering what the device already placed on the market or put into service is intended to do.
• Modifying the device. Changing a device already on the market or in service in a way that may affect its compliance with the applicable requirements.

The first trigger has a built-in escape hatch — a documented agreement that keeps the original manufacturer on the label and on the hook. The third is where the article's real complexity lives, because "modification" is broad enough to capture ordinary distribution activity unless Article 16(2) narrows it back down.

The Article 16(2) exemption — a conjunctive test, not a menu

Article 16(2) does not exempt repackaging or relabelling outright. It narrows the third Article 16(1) trigger — "modification" — by specifying two categories of activity that are not, by themselves, considered a modification capable of affecting compliance: providing information, including translation, of the manufacturer's own labeling and instructions for use, together with any further information necessary to market the device in the relevant Member State; and changes to the device's outer packaging, including a change of pack size, where that repackaging is necessary to market the device in the relevant Member State. Both categories carry the same qualifying language, and it does real work: the activity has to be necessary to market the device in that Member State, and it has to be carried out under conditions that leave the device's original condition unaffected. A distributor that translates an IFU it didn't need to translate, or repackages in a way that risks the device's original condition, is outside the exemption even if the underlying activity looks routine. Confirming which side of that line an activity sits on is exactly the kind of question that belongs inside a CE marking compliance review, not an afterthought to it.

Article 16(2) is a conjunctive test. "Necessary to market in that Member State" and "original condition preserved" both have to be true — satisfying one without the other does not get you the exemption. Why the two-condition reading matters

What Article 16(3) and (4) require once you're inside the exemption

Falling inside the Article 16(2) exemption does not mean the activity is unregulated — it means a different, narrower set of obligations applies instead of the full manufacturer file. Article 16(3) requires the distributor or importer to have a quality management system covering exactly the two exposures the exemption turns on: procedures to ensure the translated information stays accurate and up to date, and procedures to ensure repackaging and relabelling activities are performed by means and under conditions that preserve the device's original condition, with packaging that is not defective, of poor quality, or untidy. Article 16(4) then adds the notification mechanics: at least 28 days before making the relabelled or repackaged device available, the distributor or importer must inform both the original manufacturer and the competent authority of the Member State where it plans to make the device available, and, on request, provide a sample or mock-up of the relabelled or repackaged device, including any translated label and instructions for use. Within that same 28-day window, the distributor or importer must submit to the competent authority a certificate, issued by a notified body designated for the relevant device type and packaging scope, attesting that its quality management system complies with paragraph 3 — the Article 16(4) certification the Medical Device Coordination Group's guidance addresses in detail.

It is worth being precise about what Article 16 is not. The general verification duties every distributor and importer carries under Articles 13 and 14 — checking CE marking, the declaration of conformity, and UDI compliance before making a device available — are a different, lower bar than becoming the manufacturer; we cover that ground separately in economic operator obligations. Article 16 is the line past that baseline: the point where an activity stops being verification and starts being an alteration the MDR treats as manufacturing. Companies that run the Article 16(1) trigger assessment before they design a private-label or repackaging program, rather than after a notified body or competent authority raises it, are the ones who end up needing a certification sequence — not a remediation plan.